Company · Kirkland, Quebec, Canada
Jubilant Draximage Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 18
- 15 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 3
- 1 active
- Notices of Compliance
- 27
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| DRAX EXAMETAZIMEStatus since Feb 2026 | 02495848 | Marketed | |
| DRAXIMAGE DTPAStatus since Jun 2018 | 02329727 | Marketed | |
| DRAXIMAGE GLUCEPTATEStatus since Aug 2018 | 02342006 | Marketed | |
| DRAXIMAGE MAAStatus since Aug 2018 | 02329417 | Marketed | |
| DRAXIMAGE MDPStatus since Aug 2018 | 02329409 | Marketed | |
| DRAXIMAGE MDP-25Status since Aug 2018 | 02329239 | Marketed | |
| DRAXIMAGE SESTAMIBIStatus since Aug 2018 | 02327732 | Marketed | |
| DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP DIAGNOSTICStatus since Nov 2018 | 02329751 | Marketed | |
| DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTICStatus since Nov 2018 | 02329743 | Marketed | |
| DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTICStatus since Nov 2018 | 02329786 | Marketed | |
| DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTICStatus since Nov 2018 | 02329778 | Marketed | |
| RUBY-FILLStatus since Sep 2018 | 02374285 | Marketed | |
| HICONStatus since Jul 2019 | 02327864 | Dormant | |
| HICONStatus since Jul 2019 | 02482320 | Dormant | |
| HICONStatus since Jul 2019 | 02482339 | Dormant | |
| DRAXIMAGE XENON XE 133Status since Oct 2016 | 02360268 | Cancelled Post Market | |
| DRAXIMAGE XENON XE 133Status since Oct 2016 | 02360276 | Cancelled Post Market | |
| GADOPENTETATE DIMEGLUMINE INJECTION, USPStatus since May 2022 | 02431513 | Cancelled Pre Market |
Medical device licences
Active licences first, newest first.
| Name | Licence | Status | First licensed |
|---|---|---|---|
| RUBY RUBIDIUM ELUTION SYSTEMFirst licensed Sep 2017 | 99745 | Issued (active) · Class 2 | |
| BRACHYSEED PD-103First licensed Jul 2001 | 30780 | Cancelled · Class 3 | |
| BRACHYSEEDFirst licensed Apr 2000 | 19697 | Cancelled · Class 3 |
Notices of Compliance
Newest first.
- DRAX EXAMETAZIMEFebruary 27, 2026 · NOC 37082 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DRAXIMAGE MAADecember 22, 2025 · NOC 36635 · Supplement to a New Drug Submission (SNDS)
- DRAXIMAGE SESTAMIBINovember 28, 2025 · NOC 36448 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DRAXIMAGE GLUCEPTATENovember 1, 2024 · NOC 34477 · Supplement to a New Drug Submission (SNDS)
- DRAXIMAGE SODIUM IODIDE I 131 CAPSULES, USP DIAGNOSTIC; DRAXIMAGE SODIUM IODIDE I 131 CAPSULES, USP THERAPEUTIC; DRAXIMAGE SODIUM IODIDE I 131 SOLUTION, USP DIAGNOSTIC; DRAXIMAGE SODIUM IODIDE I 131 SOLUTION, USP THERAPEUTICNovember 24, 2023 · NOC 32280 · Supplement to a New Drug Submission (SNDS)
- DRAXIMAGE MDP; DRAXIMAGE MDP-25May 4, 2022 · NOC 28093 · Supplement to a New Drug Submission (SNDS)
- DRAXIMAGE DTPAMarch 11, 2022 · NOC 27749 · Supplement to a New Drug Submission (SNDS)
- RUBY-FILLMay 28, 2021 · NOC 25954 · Supplement to a New Drug Submission (SNDS)
- DRAXIMAGE DTPAFebruary 17, 2021 · NOC 25244 · Supplement to a New Drug Submission (SNDS)
- DRAX EXAMETAZIMEJanuary 23, 2020 · NOC 23135 · Abbreviated New Drug Submission (ANDS)
- RUBY-FILLDecember 21, 2018 · NOC 21650 · Supplement to a New Drug Submission (SNDS)
- RUBY-FILL (RUBIDIUM RB-82 GENERATOR)November 21, 2014 · NOC 16323 · Supplement to a New Drug Submission (SNDS)
- DRAXIMAGE SESTAMIBIOctober 8, 2014 · NOC 16165 · Supplement to an Abbreviated New Drug Submission (SANDS)
- GADOPENTETATE DIMEGLUMINE INJECTION USPSeptember 22, 2014 · NOC 16121 · Abbreviated New Drug Submission (ANDS)
- DRAXIMAGE SODIUM IODIDE I 131 CAPSULEMarch 26, 2013 · NOC 14242 · Supplement to a New Drug Submission (SNDS)
- DRAXIMAGE MDP-25August 30, 2012 · NOC 13609 · Supplement to a New Drug Submission (SNDS)
- RUBY-FILLJuly 25, 2012 · NOC 13514 · Supplement to a New Drug Submission (SNDS)
- HICONApril 3, 2012 · NOC 13186 · Supplement to a New Drug Submission (SNDS)
- RUBY-FILLSeptember 20, 2011 · NOC 12635 · New Drug Submission (NDS)
- DRAXIMAGE SODIUM IODIDE I 131 CAPSULES AND SOLUTION USPApril 14, 2011 · NOC 12268 · New Drug Submission (NDS)
- DRAXIMAGE MAADecember 31, 2010 · NOC 11966 · New Drug Submission (NDS)
- DRAXIMAGE GLUCEPTATEDecember 31, 2010 · NOC 11967 · New Drug Submission (NDS)
- HICONDecember 31, 2010 · NOC 11968 · New Drug Submission (NDS)
- DRAXIMAGE DTPADecember 31, 2010 · NOC 11969 · New Drug Submission (NDS)
- DRAXIMAGE SESTAMIBIDecember 31, 2010 · NOC 11970 · Abbreviated New Drug Submission (ANDS)
- DRAXIMAGE MDP; DRAXIMAGE MDP-25December 31, 2010 · NOC 11971 · New Drug Submission (NDS)
- DRAXIMAGE XENON XE 133December 31, 2010 · NOC 11972 · New Drug Submission (NDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Ruby-Fill Rubidium 82 Generator (2015-12-07)December 7, 2015 · Drugs · Product safety · Type II